Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non Transplantable Recurrence After Percutaneous Thermal Ablation of ≤3cm HCC: Predictors and Implications for Treatment Allocation

NCT05202184 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT05202184
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05202184 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non Transplantable Recurrence After Percutaneous Thermal Ablation of ≤3cm HCC: Predictors and Implications for Treatment Allocation
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
January 1, 2015
Completion date
December 30, 2020
Enrollment
213 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcc